Navigation Links
Leukemia pill shows promise against stomach cancer

Gleevec, which was just approved for treating leukemia, also shows promise against a type of stomach cancer . The Food and Drug Administration approved the use of a promising anti-leukemia drug for treatment of a relatively rare form of abdominal cancer. The drug, Gleevec, administered as a pill once a day, is effective in treating both forms of cancer because of its ability to target and kill cancer cells without attacking healthy cells and causing severe side effects. //

Approved last spring for a common type of adult leukemia, Gleevec can now be used to treat gastrointestinal stromal tumors, or GIST, which affect as many as 5,000 people in the US each year. Studies have shown it to be as effective in treating chronic cases of GIST as it has been in treating chronic myelogenous leukemia (CML).

Researchers reported 59 percent of patients with advanced-stage GIST went into remission and up to 75 percent showed some type of improvement with limited side effects. GIST accounts for about two percent of all abdominal cancers. If caught early, these tumors can usually be removed surgically, but growths often return. According to its manufacturer, Novartis Oncology, Gleevec also is being studied as a possible treatment for prostate cancer, small-cell lung cancer and a rare type of brain cancer.
'"/>




Page: 1

Related medicine news :

1. Cyclosporin A Treats Leukemia Complications
2. Aspirin Lowers Leukemia Risk
3. Hope for Chemo-Resistant Leukemia Patients
4. Genes Found To Help Leukemia Treatment
5. Looking Towards More Effective Leukemia Treatment
6. Diet Found To Offer Protection Against Leukemia
7. Exposure To Night Light may Increase The Risk Of Leukemia
8. Skin Allergies Found To Increase The Risk Of Leukemia
9. Understanding Gene Profiles Could Help Cure A Resistant Form Of Leukemia In Kids
10. Night Light Found To Increase The Risk Of Leukemia
11. Treating Leukemia With Natural Cells
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/22/2017)... Jacksonville, FL (PRWEB) , ... March 22, 2017 ... ... (ASPC) convened experts to create a PCSK9 inhibitor prior authorization (PA) form for ... high cholesterol. It is one of the helpful tools published as part of ...
(Date:3/22/2017)... ... 22, 2017 , ... Wash Tower Ltd. has released a series of six ... the world's first standalone constant pressure bidet. , The videos in the series titled ... https://www.washtower.com as well as on its social media pages. , Each video stars ...
(Date:3/22/2017)... ... 22, 2017 , ... University Orthopedics (UOI) today announced the ... Hand, Upper Extremity and Microvascular Surgery at Newport Hospital. Dr. Bragdon specializes in ... and Hand Surgery. , As the leader of comprehensive orthopedic care in ...
(Date:3/22/2017)... ... March 22, 2017 , ... SNL Insurance and Financial, a ... business owners in the greater Hampton Roads area, is embarking on a community ... Life event. , Each year, hundreds of people living in the South Hampton ...
(Date:3/22/2017)... , ... March 22, 2017 , ... ... planning assistance, and related services to families and business owners in the greater ... with the Leukemia & Lymphoma Society. , Every 3 minutes, someone in America ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... March 22, 2017 Under the impetus ... packaging market size increased year by year at ... to 2021, the market size will maintain the ... to outnumber RMB140 billion in 2021, thanks to ... development of biological agents and supporting policies. ...
(Date:3/22/2017)... March 22, 2017 New Jersey,s ... of patient harm and saved $641 million in healthcare ... in a national quality improvement program. ... for Patients-New Jersey, part of a national initiative from ... selected the New Jersey Hospital Association and its affiliate, ...
(Date:3/22/2017)... Mar 22, 2017 Research and Markets ... Point Inhibitors Market & Clinical Pipeline Insight 2022" drug ... ... & Clinical Pipeline Insight 2022 report gives comprehensive insight on ... of immune check point inhibitors as main streamline drugs in ...
Breaking Medicine Technology: